Pancreatic Cancer Research

ResearcherSheng Jing HospitalNo recent work listed

Xiang Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-1081-6382; OpenAlex author ID A5053119723. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Sparstolonin B inhibits pancreatic adenocarcinoma through the NF-κB signaling pathway. Last author DOI 10.1016/j.yexcr.2022.113214↗
  2. Pilot trial of endoscopic ultrasound-guided interstitial chemoradiation of UICC-T4 pancreatic cancer. Co-author DOI 10.4103/2303-9027.117773↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yang Lyu · 1 shared paper, 2022 · strength 0.17
  2. Jintao Guo · 1 shared paper, 2012 · strength 0.04
  3. Sheng Wang · 1 shared paper, 2012 · strength 0.04
  4. Nan Ge · 1 shared paper, 2012 · strength 0.04
  5. Siyu Sun · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.